Endogenous PKI gamma limits the duration of the anti-apoptotic effects of PTH and beta-adrenergic agonists in osteoblasts.
about
Beta-1 adrenergic agonist treatment mitigates negative changes in cancellous bone microarchitecture and inhibits osteocyte apoptosis during disuse.The small GTPase RhoA is crucial for MC3T3-E1 osteoblastic cell survival.Investigational anabolic therapies for osteoporosis.Protein kinase inhibitor γ reciprocally regulates osteoblast and adipocyte differentiation by downregulating leukemia inhibitory factor.Liraglutide Inhibits the Apoptosis of MC3T3-E1 Cells Induced by Serum Deprivation through cAMP/PKA/β-Catenin and PI3K/AKT/GSK3β Signaling Pathways.
P2860
Endogenous PKI gamma limits the duration of the anti-apoptotic effects of PTH and beta-adrenergic agonists in osteoblasts.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Endogenous PKI gamma limits th ...... ergic agonists in osteoblasts.
@en
type
label
Endogenous PKI gamma limits th ...... ergic agonists in osteoblasts.
@en
prefLabel
Endogenous PKI gamma limits th ...... ergic agonists in osteoblasts.
@en
P2093
P356
P1476
Endogenous PKI gamma limits th ...... ergic agonists in osteoblasts.
@en
P2093
Edward M Greenfield
In-Hwan Song
James E Dennis
P2860
P304
P356
10.1359/JBMR.070122
P577
2007-05-01T00:00:00Z